Wockhardt Puts Up Superbug Fight With Punchy Broad Spectrum Antibiotic

Wockhardt has received approvals in India for two novel broad spectrum antibiotics with "advantageous" safety features over older MRSA drugs and the firm hopes to take them to other emerging markets as well, with China on the radar.

Viral disease
Wockhardt's Novel Antibiotics Get Go Ahead In India • Source: Shutterstock

More from India

More from Focus On Asia